November 18, 2024
Community Shares | November 18th 2024
- New British research has explored the prevalence of physical health conditions in individuals with autism compared to a control group without autism or mental health conditions.
- A new study published in ACS Nano demonstrates a promising biomedical tool that delivers genetic material to fetal brain cells, potentially halting the progression of neurodevelopmental disorders like Angelman syndrome and Rett syndrome before birth.
- Egyptian researchers recently analyzed the gut microbiome composition in children with ASD compared to typically developing (TD) children, emphasizing species-level analysis.
- Autism BrainNet, a program of the Simons Foundation, reported a 39% increase in brain donations from 2022-2023 compared to the previous three years, aiding critical autism research.
May 27, 2024
Familial Fecal Microbiota Transplantation Shows Promise in Treating Autism Symptoms
In a fascinating new case report, researchers, including Steven J. Walker, PhD, documented significant improvements in both gut microbiome composition and autism spectrum disorder (ASD) symptoms after familial fecal microbiota transplantation (FMT) was performed in an adolescent with ASD.
April 30, 2020
Improvement from 6 Month Probiotic/Prebiotic Treatment for Autism
A new study [1] confirms differences in gut microbiome composition between autistic children and typically developing children, and has reported improvement in autism symptomatology with a probiotic/prebiotic treatment. Improvements were seen in gut microbiome diversity, metabolites and function, as well as autism behaviors and neurotransmitters.
